tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN
US Market

Urogen Pharma (URGN) Income Statement

Compare
469 Followers

Urogen Pharma Income Statement

Last quarter (Q4 2024), Urogen Pharma's total revenue was $24.57M, an increase of 4.40% from the same quarter last year. In Q4, Urogen Pharma's net income was $-37.51M. See Urogen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 90.40M$ 82.71M$ 64.36M$ 48.04M$ 11.80M
Gross Profit
$ 81.52M$ 73.35M$ 56.70M$ 42.88M$ 10.79M
Operating Expenses
$ 178.30M$ 138.89M$ 135.74M$ 135.18M$ 137.53M
Depreciation and Amortization
$ 1.19M$ 1.71M$ 1.82M$ 1.77M$ 2.04M
EBITDA
$ -110.33M$ -63.83M$ -78.03M$ -90.15M$ -122.71M
Operating Income
$ -96.78M$ -65.54M$ -79.04M$ -92.29M$ -126.74M
Other Income/Expenses
$ -27.26M$ -32.79M$ -28.99M$ -17.08M$ 1.63M
Pretax Income
$ -124.04M$ -98.32M$ -108.03M$ -109.37M$ -125.11M
Net Income
$ -126.87M$ -102.24M$ -109.16M$ -110.82M$ -128.48M
Per Share Metrics
Basic EPS
$ -2.96$ -3.55$ -4.79$ -4.96$ -5.90
Diluted EPS
$ -2.96$ -3.55$ -4.79$ -4.96$ -5.90
Weighted Average Shares Outstanding
42.88M 28.83M 22.81M 22.35M 21.78M
Weighted Average Shares Outstanding (Diluted)
42.88M 28.83M 22.81M 22.35M 21.78M
Currency in USD

Urogen Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis